Evidence map›Paper›PMID 39681711›Full record

ArticleEye (London, England)2025

Leveraging large language models to improve patient education on dry eye disease.

Qais A Dihan, Andrew D Brown, Muhammad Z Chauhan, Ahmad F Alzein, Seif E Abdelnaem, Sean D Kelso, Dania A Rahal, Royce Park, Mohammadali Ashraf, Amr Azzam and 5 more

Abstract read
In one paragraph

Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Qais A DihanChicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
Andrew D BrownUAMS College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Muhammad Z ChauhanUAMS College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Ahmad F AlzeinCollege of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Seif E AbdelnaemCollege of Natural Sciences and Mathematics, University of Central Arkansas, Conway, AR, USA.
Sean D KelsoBurnett School of Medicine, Texas Christian University, Fort Worth, TX, USA.
Dania A RahalUAMS College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Royce ParkDepartment of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, USA.
Mohammadali AshrafDepartment of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, USA.
Amr AzzamDepartment of Ophthalmology, Kasr Al-Ainy Hospitals, Cairo University, Cairo, Egypt.
Mahmoud MorsiDepartment of Anesthesia and Pain Management, Kasr Al-Ainy Hospitals, Cairo University, Cairo, Egypt.
David B WarnerDepartment of Ophthalmology, Harvey and Bernice Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Ahmed B SallamDepartment of Ophthalmology, Harvey and Bernice Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Hajirah N SaeedDepartment of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL, USA. hnsaeed@uic.edu.ORCID http://orcid.org/0000-0002-7385-6534
Abdelrahman M ElhusseinyDepartment of Ophthalmology, Harvey and Bernice Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. AMELhusseiny@uams.edu.ORCID http://orcid.org/0000-0003-1412-375X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesDry eye disease (DED) is an exceedingly common diagnosis in patients, yet recent analyses have demonstrated patient education materials (PEMs) on DED to be of low quality and readability. Our study evaluated the utility and performance of three large language models (LLMs) in enhancing and generating new patient education materials (PEMs) on dry eye disease (DED). SUBJECTS/

methodsWe evaluated PEMs generated by ChatGPT-3.5, ChatGPT-4, Gemini Advanced, using three separate prompts. Prompts A and B requested they generate PEMs on DED, with Prompt B specifying a 6th-grade reading level, using the SMOG (Simple Measure of Gobbledygook) readability formula. Prompt C asked for a rewrite of existing PEMs at a 6th-grade reading level. Each PEM was assessed on readability (SMOG, FKGL: Flesch-Kincaid Grade Level), quality (PEMAT: Patient Education Materials Assessment Tool, DISCERN), and accuracy (Likert Misinformation scale).

resultsAll LLM-generated PEMs in response to Prompt A and B were of high quality (median DISCERN = 4), understandable (PEMAT understandability ≥70%) and accurate (Likert Score=1). LLM-generated PEMs were not actionable (PEMAT Actionability <70%). ChatGPT-4 and Gemini Advanced rewrote existing PEMs (Prompt C) from a baseline readability level (FKGL: 8.0 ± 2.4, SMOG: 7.9 ± 1.7) to targeted 6th-grade reading level; rewrites contained little to no misinformation (median Likert misinformation=1 (range: 1-2)). However, only ChatGPT-4 rewrote PEMs while maintaining high quality and reliability (median DISCERN = 4).

conclusionLLMs (notably ChatGPT-4) were able to generate and rewrite PEMs on DED that were readable, accurate, and high quality. Our study underscores the value of leveraging LLMs as supplementary tools to improving PEMs.

Indexed as

Dry Eye SyndromesPatient Education as TopicTeaching MaterialsComprehensionHealth LiteracyHumansLarge Language ModelsReading

Identifiers

PMID39681711
PMCPMC11978745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.